Skip to main content

Table 1 Patient characteristics

From: I-123 iomazenil single photon emission computed tomography for detecting loss of neuronal integrity in patients with traumatic brain injury

Patient no. Age (year) Sex WAIS-R, WAIS-III, WISC-III RBMT Diagnosis at the time of the accident Period after injury (month) Main symptoms
    FIQ VIQ PIQ    FMZ IMZ  
1 28 M 98 105 90 21 No definite abnormalities 10 10 Irritability, poor concentration
2 51 M 100 99 100 20 Cerebral contusion 17 32 Difficulty of calculation
3 39 M 104 111 94 16 No definite abnormalities 4 10 Memory disorder
4 16 M 75 92 66 22 No definite abnormalities 2 13 Memory disorder
5 21 M 90 98 105 17 Cerebral contusion 2 6 Mental fatigue
6 28 F 85 84 90 23 Traumatic SAH, DAI, contusion 4 39 Memory disorder
7 29 F 106 101 101 22 ASDH 3 14 Mental fatigue
  1. M male, F female, WAIS-R Wechsler Adult Intelligence Scale-Revised, WAIS-III Wechsler Adult Intelligence Scale-III, WISC-III Wechsler Intelligence Scale for Children-III, FIQ full intelligence quotient, VIQ verbal intelligence quotient, PIQ performance intelligence quotient, RBMT Rivermead Behavioral Memory Test, SAH subarachnoid hemorrhage, DAI diffuse axonal injury, ASDH acute subdural hematoma, FMZ C-11 flumazenil, IMZ I-123 iomazenil